AU2007241622A1 - Improved treatment of cystic fibrosis - Google Patents

Improved treatment of cystic fibrosis Download PDF

Info

Publication number
AU2007241622A1
AU2007241622A1 AU2007241622A AU2007241622A AU2007241622A1 AU 2007241622 A1 AU2007241622 A1 AU 2007241622A1 AU 2007241622 A AU2007241622 A AU 2007241622A AU 2007241622 A AU2007241622 A AU 2007241622A AU 2007241622 A1 AU2007241622 A1 AU 2007241622A1
Authority
AU
Australia
Prior art keywords
deoxynojirimycin
group
use according
carbon atoms
gba2
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2007241622A
Other languages
English (en)
Other versions
AU2007241622A8 (en
Inventor
Johannes Maria Franciscus Gerardus Aerts
Rolf Gabriel Boot
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Academisch Medisch Centrum
Original Assignee
Academic Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Academic Medical Center filed Critical Academic Medical Center
Publication of AU2007241622A1 publication Critical patent/AU2007241622A1/en
Publication of AU2007241622A8 publication Critical patent/AU2007241622A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Epoxy Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
AU2007241622A 2006-04-24 2007-04-24 Improved treatment of cystic fibrosis Abandoned AU2007241622A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US79408806P 2006-04-24 2006-04-24
US60/794,088 2006-04-24
PCT/NL2007/050177 WO2007123403A1 (en) 2006-04-24 2007-04-24 Improved treatment of cystic fibrosis

Publications (2)

Publication Number Publication Date
AU2007241622A1 true AU2007241622A1 (en) 2007-11-01
AU2007241622A8 AU2007241622A8 (en) 2008-12-04

Family

ID=38283020

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2007241622A Abandoned AU2007241622A1 (en) 2006-04-24 2007-04-24 Improved treatment of cystic fibrosis

Country Status (10)

Country Link
US (1) US8410081B2 (https=)
EP (1) EP2010551B1 (https=)
JP (1) JP2009538276A (https=)
CN (1) CN101479288B (https=)
AT (1) ATE479696T1 (https=)
AU (1) AU2007241622A1 (https=)
BR (1) BRPI0710883A2 (https=)
CA (1) CA2650311A1 (https=)
DE (1) DE602007008870D1 (https=)
WO (1) WO2007123403A1 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0712494D0 (en) 2007-06-27 2007-08-08 Isis Innovation Substrate reduction therapy
CA2753195C (en) 2009-02-23 2015-06-02 United Therapeutics Corporation Iminosugars and methods of treating viral diseases
ES2562635T3 (es) * 2009-02-24 2016-03-07 United Therapeutics Corporation Iminoazúcares y métodos de tratamiento de infecciones producidas por arenavirus
CN102639133B (zh) 2009-06-12 2015-03-11 联合治疗公司 亚氨基糖和治疗布尼亚病毒性疾病以及披膜病毒性疾病的方法
WO2011028779A1 (en) * 2009-09-04 2011-03-10 United Therapeutics Corporation Iminosugars and methods of treating filoviral diseases
CN102625801B (zh) * 2009-09-04 2015-09-09 联合治疗公司 治疗痘病毒感染的方法
KR101497194B1 (ko) * 2009-09-04 2015-02-27 유나이티드 세러퓨틱스 코오포레이션 오르토믹소바이러스 감염의 치료 방법
GB201000499D0 (en) 2010-01-13 2010-03-03 Fleet George W J Treatment of cystic fibrosis
WO2011095772A2 (en) 2010-02-04 2011-08-11 Summit Corporation Plc Novel iminosugar therapeutics
GB201006434D0 (en) 2010-04-19 2010-06-02 Summit Corp Plc Novel iminosugar combinations
US10350277B2 (en) 2011-09-07 2019-07-16 Icahn School Of Medicine At Mount Sinai Ceramidase and cell differentiation
PL2854910T3 (pl) 2012-06-01 2020-07-27 Icahn School Of Medicine At Mount Sinai Poziomy ceramidu w leczeniu i zapobieganiu infekcjom
US20150346185A1 (en) * 2012-12-05 2015-12-03 Institut National De La Sante Et De La Recherche Medicale (Inserm) Diagnosis of cystic fibrosis
CA2905449C (en) 2013-03-14 2024-09-10 Icahn School Of Medicine At Mount Sinai THERAPEUTIC COMPOSITIONS OF ACID CERAMIDASE AND THEIR PROCESSES OF MANUFACTURE AND USE
US20190142782A1 (en) 2016-04-11 2019-05-16 Spedding Research Solutions Inhibitors of glucosylceramide degradation in the treatment of diseases of the motor units
AU2018278247B2 (en) 2017-06-01 2022-07-28 Idorsia Pharmaceuticals Ltd Crystalline form of N-butyldeoxygalactonojirimycin
AU2022235284A1 (en) * 2021-03-12 2023-10-05 Excepgen Inc. Systems and methods for protein expression

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6177447B1 (en) * 1996-07-15 2001-01-23 Universiteit Van Amsterdam Deoxynojirimycin derivatives and their uses as glucosylceramidase inhibitors
AU5799500A (en) 1999-06-29 2001-01-22 Mcgill University Human alpha 1,2-mannosidase
EP1528056A1 (en) * 2003-10-29 2005-05-04 Academisch Ziekenhuis bij de Universiteit van Amsterdam Deoxynojirimycin analogues and their uses as glucosylceramidase inhibitors
FR2861991B1 (fr) * 2003-11-07 2008-01-18 Centre Nat Rech Scient Utilisation d'inhibiteurs de glucosidase pour une therapie de la mucoviscidose
WO2005123055A2 (en) 2004-06-14 2005-12-29 Musc Foundation For Research Development Methods for treating inflammatory disorders
AU2006272497B2 (en) 2005-07-27 2012-07-19 University Of Florida Research Foundation, Inc. Small compounds that correct protein misfolding and uses thereof

Also Published As

Publication number Publication date
EP2010551A1 (en) 2009-01-07
ATE479696T1 (de) 2010-09-15
JP2009538276A (ja) 2009-11-05
DE602007008870D1 (de) 2010-10-14
CN101479288A (zh) 2009-07-08
CA2650311A1 (en) 2007-11-01
BRPI0710883A2 (pt) 2011-08-09
AU2007241622A8 (en) 2008-12-04
WO2007123403A1 (en) 2007-11-01
US8410081B2 (en) 2013-04-02
CN101479288B (zh) 2012-06-27
US20090186862A1 (en) 2009-07-23
EP2010551B1 (en) 2010-09-01

Similar Documents

Publication Publication Date Title
US8410081B2 (en) Treatment of cystic fibrosis
ES2354976T3 (es) Fosfatasa alcalina placentaria para controlar la diabetes.
US8138158B2 (en) Compositions and methods for therapy for diseases characterized by defective chloride transport
US20030096762A1 (en) Compositions and methods for cystic fibrosis therapy
US20110082099A1 (en) Methods and Compositions for the Treatment of Cystic Fibrosis and Related Illnesses
US20020115619A1 (en) Compositions and methods for treatment of cystic fibrosis
KR100969634B1 (ko) 글루코사민 또는 글루코사민 유도체를 포함하는 아토피성피부염 치료용 조성물 및 이를 사용하여 아토피성 피부염을치료하는 방법
US7662838B2 (en) Use of a deoxynojirimycin derivative or a pharmaceutically salt thereof
US6656912B2 (en) Methods to treat α1-antitrypsin deficiency
WO2020261230A1 (en) Combination therapy with acetyl-leucine and miglustat
EP4631508A2 (en) Novel association of gastrodia elata and vitamin d
KR101297763B1 (ko) 알츠하이머 병 치료용 의약의 제조를 위한 ｓ-아데노실메티오닌(ｓａｍ) 및 슈퍼옥시드 디스뮤타아제(ｓｏｄ)의 용도
TWI742699B (zh) 醫藥組合物用於製備促發炎細胞介素抑制劑及製備治療細胞介素釋放症候群的藥品之用途
EP4574142A1 (en) Composition for use in enhancing, boosting, restoring and/or preventing the decline of cognitive functions
JPH0672884A (ja) α‐アミラーゼ阻害剤及びそれを用いた医薬
WO2024036044A1 (en) Compositions and methods for treating and preventing metabolic disorders
ES2357742T3 (es) N-(5-adamantano-1-il-metoxi-pentil)desoxinojirimicina o una sal farmacéuticamente aceptable de la misma para el uso en el tratamiento de la resistencia a la insulina.
Hooi Actions of balsalazide and sulphasalazine on mast cells

Legal Events

Date Code Title Description
TH Corrigenda

Free format text: IN VOL 22, NO 46, PAGE(S) 5403 UNDER THE HEADING PCT APPLICATIONS THAT HAVE ENTERED THE NATIONAL PHASE - NAME INDEX UNDER THE NAME ACADEMISCH MEDISH CENTRUM, APPLICATION NO. 2007241622 UNDER INID (71), CORRECT THE APPLICANT NAME TO ACADEMISCH MEDISCH CENTRUM

MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period